Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Nov. 27, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

Nyotran progresses towards market introduction

Nov. 25, 1996

New class of antibacterial agents discovered by Zeneca

Nov. 25, 1996

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...